| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/05/2011 | US20110105434 2-amino purine derivatives and their use as anti-herpetic agents |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105426 Compositions and methods for treating corneal inflammation |
| 05/05/2011 | US20110105423 Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof |
| 05/05/2011 | US20110105421 Ellagitannins as inhibitors of bacterial quorum sensing |
| 05/05/2011 | US20110105419 Pharmacological adjuvants based on coordination compounds of d-metals |
| 05/05/2011 | US20110105416 Novel Antimicrobial Peptides |
| 05/05/2011 | US20110105415 Gene regulator |
| 05/05/2011 | US20110105395 Methods for treating a neurological disorder by peripheral administration of a trophic factor |
| 05/05/2011 | US20110105387 Method of treatment with rapamycin |
| 05/05/2011 | US20110105386 Use of antimicrobial polymers for re-sensitization of microorganisms upon emergence of resistance to anti-microbial agents |
| 05/05/2011 | US20110105385 Antibacterial lactobacillus GG peptides and methods of use |
| 05/05/2011 | US20110105383 Methods and compositions for stimulation of mammalian innate immune resistance to pathogens |
| 05/05/2011 | US20110104313 Compositions for the treatment of vaginal infections with chronic inflammation |
| 05/05/2011 | US20110104308 Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide |
| 05/05/2011 | US20110104303 Material having antimicrobial activity when wet |
| 05/05/2011 | US20110104302 Composition and method for treating viral conditions |
| 05/05/2011 | US20110104296 Endorphin Therapy Compositions and Methods |
| 05/05/2011 | US20110104293 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors |
| 05/05/2011 | US20110104286 Pharmaceutical compositions containing the enzyme cyprosin, an aspartic peptidase from cynara cardunculus and its inclusion in antitumour formulations |
| 05/05/2011 | US20110104267 Pharmaceutical compositions of antiretrovirals |
| 05/05/2011 | US20110104263 Claudin-4 binding peptides, compositions and methods of use |
| 05/05/2011 | US20110104262 Topical Combinations Comprising an Antimycotic Agent and an Antiviral Agent |
| 05/05/2011 | US20110104260 Vaccine against varicella zoster virus |
| 05/05/2011 | US20110104248 Liposomes and immunopotentiating compositions containing the same |
| 05/05/2011 | US20110104240 Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections |
| 05/05/2011 | US20110104235 Compositions and methods for treating conditions of the nail unit |
| 05/05/2011 | US20110104219 Denture care composition |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104205 Heterologous protection against pasteurella multocida provided by p. multocida fur cells and the outer-membrane protein extracts thereof |
| 05/05/2011 | US20110104204 Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
| 05/05/2011 | US20110104203 virus-like platform for rapid vaccine discovery |
| 05/05/2011 | US20110104202 Modified Influenza Virus For Monitoring And Improving Vaccine Efficiency |
| 05/05/2011 | US20110104201 Porcine Reproductive and Respiratory Syndrome Vaccine Based on Isolate JA-142 |
| 05/05/2011 | US20110104200 Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines |
| 05/05/2011 | US20110104199 MVA Expressing Modified HIV Envelope, GAG, and POL Genes |
| 05/05/2011 | US20110104198 Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same |
| 05/05/2011 | US20110104196 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 05/05/2011 | US20110104194 Immunodominant mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization |
| 05/05/2011 | US20110104193 Combination neisserial compositions |
| 05/05/2011 | US20110104192 Norovirus and sapovirus antigens |
| 05/05/2011 | US20110104189 Compositions obtained from chlorella extract having immunomodulating properties |
| 05/05/2011 | US20110104186 Small molecule immunopotentiators and assays for their detection |
| 05/05/2011 | US20110104185 Antibody fragment-polymer conjugates and uses of same |
| 05/05/2011 | US20110104180 New vaccine for the treatment of mycobacterium related disorders |
| 05/05/2011 | US20110104179 Protease inhibitory peptides |
| 05/05/2011 | US20110104178 Novel avian astrovirus |
| 05/05/2011 | US20110104168 Detoxified pneumococcal neuraminidase and uses thereof |
| 05/05/2011 | US20110104163 Anti-hiv domain antibodies and method of making and using same |
| 05/05/2011 | US20110104159 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| 05/05/2011 | US20110104134 Novel lactic acid bacterium having high immunoglobulin-a-inducing ability |
| 05/05/2011 | US20110104121 Female Reproductive Tract and Anal Prophylaxes |
| 05/05/2011 | US20110104116 Hsa-free formulations of interferon-beta |
| 05/05/2011 | US20110104115 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 05/05/2011 | US20110104114 Polysaccharide-Protein Conjugates Reversibly Coupled Via Imine Bonds |
| 05/05/2011 | US20110104110 Substituted indole derivatives and methods of use thereof |
| 05/05/2011 | US20110104109 Tetracyclic indole derivatives and their use for treating or preventing viral infections |
| 05/05/2011 | US20110104108 Methods of treating cancer and other conditions or disease states using lfmau and ldt |
| 05/05/2011 | US20110104104 Blockage of interferon-gamma for prevention of polymicrobial synergy |
| 05/05/2011 | US20110104083 Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye |
| 05/05/2011 | US20110104078 Uv absorbing complex polyester polymers, compositions containing uv absorbing complex polyester polymers, and related methods |
| 05/05/2011 | US20110104069 Multi-functional biodegradable particles for selectable targeting, imaging, and therapeutic delivery and use thereof for treating ocular disorders |
| 05/05/2011 | US20110100371 Anti-viral properties of zosteric acid and related molecules |
| 05/05/2011 | CA2779473A1 Methods of treating viral associated diseases |
| 05/05/2011 | CA2779459A1 Peptide compositions and methods for inhibiting herpesvirus infection |
| 05/05/2011 | CA2779244A1 Dosage regimens for hcv combination therapy comprising bi201335, interferon alpha and ribavirin |
| 05/05/2011 | CA2778893A1 Dna vaccine against the yellow fever virus |
| 05/05/2011 | CA2778568A1 Antibody having activity of inhibiting hepatitis c virus (hcv) infection and use thereof |
| 05/05/2011 | CA2778540A1 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection |
| 05/05/2011 | CA2777937A1 Solid pharmaceutical compositions containing an integrase inhibitor |
| 05/05/2011 | CA2777749A1 Therapeutic peptides |
| 05/05/2011 | CA2777705A1 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom |
| 05/04/2011 | EP2316944A2 Binding agents: chimeric ligand/receptor proteins |
| 05/04/2011 | EP2316943A1 DSRNA for treating viral infection |
| 05/04/2011 | EP2316924A2 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 05/04/2011 | EP2316923A2 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 05/04/2011 | EP2316855A1 Antihuman Alpha-9 integrin antibody and use of the same |
| 05/04/2011 | EP2316852A1 Stabilized single domain antibodies |
| 05/04/2011 | EP2316839A1 Antiviral compounds |
| 05/04/2011 | EP2316487A1 Recombinant IL-9 antibodies & uses thereof |
| 05/04/2011 | EP2316481A1 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection |
| 05/04/2011 | EP2316479A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 05/04/2011 | EP2316466A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 05/04/2011 | EP2316465A1 Use of extract of leeches' saliva as anti-bacterial agent for the manufacture of different compositons |
| 05/04/2011 | EP2316455A1 Pharmaceutical compositions for treating cancer |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2316431A1 Solid oral composition comprising a S1P receptor agonist and a sugar alcohol |
| 05/04/2011 | EP2316424A1 Pharmaceutical preparations and methods for their regional administration |
| 05/04/2011 | EP2315756A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 05/04/2011 | EP2315746A1 Urea derivatives as antibacterial agents |
| 05/04/2011 | EP2128248B1 Oligonucleotide compositions with enhanced efficiency |
| 05/04/2011 | EP2019147B1 Novel k04-0144 substances and process for production thereof |
| 05/04/2011 | EP1981876B1 Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 05/04/2011 | EP1725660B1 Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 05/04/2011 | EP1633724B1 Phthalazinone derivatives |
| 05/04/2011 | EP1629091B1 Composition containing the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof |
| 05/04/2011 | EP1613397B1 Use of bacteriocin for the amelioration of digestive functionality |
| 05/04/2011 | EP1515615B1 Nutritional composition for detoxification and cancer prevention |
| 05/04/2011 | EP1373261B1 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 05/04/2011 | EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors |